Abstract
Sepsis manifests due to the host’s dysregulated immune response to an infection. High dose ascorbic acid (AA) has emerged as a potential treatment of sepsis, yet little is known regarding how ascorbic acid influences the immune system in sepsis, such as monocytes. The objective of this study is to investigate the effects of high dose AA on monocyte polarization and cytokine production in vitro.
Monocytes were isolated from healthy donors (n=6) and polarized in vitro for 48hrs using lipopolysaccharide (LPS) and lipoteichoic acid (LTA). Polarization was confirmed by surface marker expression using flow cytometry. In parallel, monocytes from septic patients (n=3) were analyzed for polarization markers as a comparison to the in vitro polarization. The effect of AA on monocyte polarization was evaluated. Finally, monocytes were analyzed for cytokine production of TNF and IL-8 by intracellular staining.
Both LPS and LTA induced polarization in healthy monocytes in vitro, with increased expression of both pro- (CD40 and PDL1, p<0.05) and anti-inflammatory (CD16 and CD163, p<0.05) polarization markers. This pattern resembled that of monocytes from septic patients. Treatment with AA significantly inhibited surface expression of CD16 and CD163 (p<0.05) in a dose dependent manner. Finally, AA attenuated LPS or LTA-induced cytokine production of IL-8 and TNF (both p<0.05) in a dose-dependent manner.
Thus, AA attenuates cytokine production and upregulation of anti-, but not pro-inflammatory related markers in LPS or LTA polarized monocytes. This study provides important insight into the effects of high dose AA on monocytes, and potential implications in sepsis.
Summary sentence Ascorbic acid inhibits production of IL-8, TNF, and upregulation of the polarization markers CD16 and CD163 in LPS or LTA polarized monocytes in vitro.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Robin Kahn is currently receiving grants from the Swedish Rheumatism Association Greta and Johan Kocks Foundation the Anna-Greta Crafoord Foundation the Crafoord Foundation the Swedish Medical Society Alfred Osterlunds Foundation The Knut and Alice Wallenberg foundation the Medical Faculty at Lund University Region Skane Fredrik Kahn is currently receiving grants from the Crafoord Foundation Alfred Osterlunds Foundation the Swedish Research council the Medical Faculty at Lund University Region Skane
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Swedish Ethical Review Authority
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Abbreviation page
- AA
- Ascorbic acid
- MFI
- Median Fluorescence Intensity
- LPS
- Lipopolysaccharide
- LTA
- lipoteichoic acid
- PBMC
- Peripheral blood mononuclear cells
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.